Clear Filters
2 results
  • NJCK 12-01

    Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for High Risk Prostate Cancer

    For inquiries, call (732) 557-8294
    • Community Medical Center
  • VERISMO

    This is a prospective, non-interventional, longitudinal, observational study of MS patients who have newly initiated treatment with ocrelizumab that is being conducted to determine the incidence and mortality rates of breast cancer and all malignancies.

    Type: Observational

    Principal Investigator: Matthew Tremblay, MD, PhD

    Website: ClinicalTrials.gov Identifier:

    This study is active, and open for enrollment.

    For inquiries, call (973) 322-7073
    • Cooperman Barnabas Medical Center
    • RWJBarnabas Health Ambulatory Care Center